5. Adam C Oken, Andreea L Turcu, Kyriakos Georgiou, Eva Tzortzini, Jessica Nagel, Yong-Chul Kim, Antonios Kolocouris, Christa E Muller, Santiago Vazquez, Steven E Mansoor BPS2025-Molecular pharmacology of human P2X7 receptor ligands visualized by cryo-EM. Biophys. J. 2025, 124 (3), 282a. 4. Gleed, M. L.; Ioannidis, H.; Kolocouris, A.; Busath, D. D. Molecular Dynamics of Amantadine Block in M2 of Influenza A: WT VS S31N. Biophysical. J. 2015, 108 (2, Supplement), 19a. 3. Kolocouris, A.; Johnson, F. B.; Zell, R.; Schmidtke, M.; Sureda, X. F.; Cross, T. A.; Busath, D. D.; Fedida, D.; Tzitzoglaki, C.; Ioannidis, H.; Hoffman, A.; López-Querol, M.; Wright, K. A.; Kwan, D.; McGuire, K.; Busath, D. D. Influenza a Blockers with Reduced Resistance Formation. Biophysical Journal 2014, 106 (2, Suppl.), 432a–433a. 2. Wright, K. A.; Hung, I.; Tzitzoglaki, C.; Ioannidis, H.; Busath, D. D.; Kolocouris, A.; Cross, T. A. Solid-State NMR Characterization of S31N M2 Transmembrane Domain Bound to Novel Adamantanes with Persistent In Vitro Efficacy. Biophysical J. 2014, 106 (2, Supplement), 659a. 1. Kolocouris, A.; Johnson, F. B.; Tzitzoglaki, C.; Gay, N. Busath, D. D. Amantadine Analogs that Inhibit MDCK Cell Infection by Influenza a with M2(S31N).
|
